you are here: HomeNewsIndia
Last Updated : Mar 27, 2020 08:07 AM IST | Source: PTI

Lockdown impact | India using multi-pronged strategy to contain COVID-19: USAIC

“To lockdown India for 21 days to contain COVID-19 was a bold and difficult decision based on scientific reasoning. No other country in the world has taken such a courageous decision to implement social distancing,” Karun Rishi, president of USA India Chamber of Commerce (USAIC) told PTI.

PTI
Janata Curfew
Janata Curfew

Terming India's 21-day nationwide lockdown as a "bold and difficult" decision, a top Indian-American pharma industry expert on March 26 said that the country is using a multi-pronged strategy to contain the deadly coronavirus.

“To lockdown India for 21 days to contain COVID-19 was a bold and difficult decision based on scientific reasoning. No other country in the world has taken such a courageous decision to implement social distancing,” Karun Rishi, president of USA India Chamber of Commerce (USAIC) told PTI.

“So far, it has appeared to dodge the full hit of the pandemic,” said Rishi.

Close

Based out of Boston, which is the hub of health and pharma sector in the US, USAIC every year organizes a US-Indian pharma summit attended by top industry and government leaders and officials from the two countries.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

“Prime Minister Narendra Modi has used multi-pronged strategy to contain and manage the COVID-19 virus in India,” he said.

The first step taken, he said, was a policy initiative last week to boost manufacturing of bulk drugs and active pharmaceutical ingredients (APIs).

Substantial financial package announced by India in these difficult economic times to encourage domestic manufacture of Key Starting Materials (KSM), drug intermediates, and active pharmaceutical ingredients (APIs) show the political will and resolve of the leadership to make India self-reliant for the domestic and export markets, he said.

“Only economies of scale in manufacturing can ensure affordable drug prices for patients. This policy envisions a set of schemes to reap economies of scale and ready availability of inputs in the production of APIs via the cluster approach. This will help India achieve drug security through self-sufficiency in manufacturing of at least 53 critical bulk drugs,” he added.

Asserting that social distancing is the only way to combat the spread of coronavirus, he noted that India with 1.3 billion people is the world's second most populous country and the fifth biggest economy. And so far, it has appeared to dodge the full hit of the pandemic, he observed.

There are less than 10,000 ICU and fewer than 40,000 isolation beds in India. A vast majority of these are already occupied by existing patients, he said.

“If India follows Italy's trajectory, for example, it would be a catastrophe, especially in the poorer Indian states, which have next to zero capacity to cope with this pandemic.

"Priority of the government was saving lives of people. India has shown effective leadership by announcing a nationwide lockdown to tackle coronavirus. This will save millions of lives,” Rishi said.
First Published on Mar 27, 2020 08:02 am
Sections